Fig. 3
From: Galectin-9 as a new biomarker of acute-on-chronic liver failure
Representative IHC staining results showing the expression of Gal-9 in CHB and ACLF tissues, and dual IF staining results showing the co-localization of Gal-9 with KC cell markers. (a) Gal-9 expression in ACLF tissues; (b) Gal-9 expression in CHB tissues; (c) quantitation of the IHC of Gal-9; (d) localization of Gal-9 to CD68 in ACLF green channel: Gal-9; red channel: CD68 and merge; (e) localization of Gal-9 to CD68 in CHB (f) quantification of the co-localization of Gal-9 and CD68 in ACLF; (g) quantification of the co-localization of Gal-9 and CD68 in CHB. IHC immunohistochemistry, Gal-9 galectin-9, ACLF acute-on-chronic liver failure, KC Kupffer cell, CHB chronic hepatitis B.
